Prix Pharma

Bevatas 100 mg Injection (Bevacizumab) is an anticancer drug used with chemotherapy to treat various advanced cancers, including metastatic colorectal, non-small cell lung, kidney, breast, cervical, ovarian, and certain brain tumors (glioblastoma) by stopping tumors from forming new blood vessels to feed them. It's an infusion given intravenously by a healthcare professional, targeting the protein VEGF to inhibit tumor growth and spread. 

Cizumab 400mg Injection (Bevacizumab) is an immunotherapy used with chemotherapy to treat various advanced cancers, including colorectal, lung (NSCLC), kidney, brain (glioblastoma), ovarian, fallopian tube, peritoneal, and cervical cancers, by blocking tumor blood vessel growth (anti-angiogenesis) to stop tumor growth and spread. It works by inhibiting VEGF, depriving tumors of nutrients and oxygen, and is administered intravenously in a clinical setting for different cancer types, often after surgery or with other agents. 

Cizumab 100mg Injection (Bevacizumab) is an anti-cancer medicine used with chemotherapy to treat various advanced cancers, including colorectal, lung, kidney, brain (glioblastoma), ovarian, fallopian tube, primary peritoneal, and cervical cancers, by stopping new blood vessels from feeding tumors. It's crucial for patients to use effective birth control during treatment and for six months after, as it can affect fertility and isn't for children under 18. 

Bevatas 400 (bevacizumab) is an anticancer injection used with chemotherapy to treat various advanced cancers like colon, rectal, lung, kidney, brain (glioblastoma), ovarian, and cervical cancers by stopping tumors from growing new blood vessels. It's given intravenously by a healthcare professional, not self-injected, and requires strict contraception for women of childbearing age due to risks to unborn babies. 

Vivitra 150mg Injection (Trastuzumab) is a targeted therapy for HER2-positive cancers, primarily used for HER2-positive breast cancer (early-stage and metastatic) and metastatic stomach (gastric) cancer. It works by blocking HER2 protein signals that tell cancer cells to grow and spread, slowing tumor growth and often given with chemotherapy.